A medicine branch, hematology is referred to as the study of blood-forming organs, blood, and blood diseases. It comprises issues associated with red blood cells, platelets, white blood cells, lymph, and bone marrow. Also, it impacts the liquid constituent of blood called plasma. It consists of numerous IVD technologies like flow cytometry, blood analysis, hemostasis, molecular diagnostics, cytology immunodiagnostics, and histology. Few of the hematology diagnostics systems are hematology reagents, hemostatis, hematology rapid tests, and immunohematology.
The growth of the global hematology diagnostics market is expected to be mainly driven by the rising incidence of blood disorders and the growing alertness regarding these disorders, the existence of advanced & cutting-edge technologies. Further, the POC (point-Of-care) hematology tests are convenient as they decrease the requirement for user training along with facilitating remote testing. In addition, the turnaround time is also decreased with these tests. Thus, growing implementation of these tests is projected to propel the market expansion during the forecast period. Also, increasing initiatives by government to back healthcare infrastructure is expected to surge market growth.
The global hematology diagnostics market can be segregated on the basis of end-user, product type, and region. The global market, by product type, is categorized into hematology consumables and hematology instruments. Among these, the market is likely to be governed by hematology consumables segment during the forecast period owing to the increase in alertness about blood disorders among people and healthcare professionals. The global market, based on end-user, is classified into academic institutes, hospitals & clinics, diagnostic laboratories, and others.
Regionally, the global hematology market is expected to be ruled by North America and trailed by Europe. The expansion of North America market can be attributed to factors such as the accessibility to a huge count of diagnostic centers along with growing R&D investments. In addition, Asia Pacific region is also projected to display a higher CARG during coming period owing to the enhancing healthcare infrastructure in this region. India and China are anticipated to register quick growth owing to the huge patient pools, growing need for technologically progressive diagnosis devices, and elevating buying power of customers.
Few of the major players profiled within the global hematology diagnostics market consist of Hemocue, Abbott Laboratories, Siemens Healthcare diagnostics, Horiba, Bio-Rad Laboratories, Beckman Coulter, Roche Diagnostics, and Nihon Kohden Corporation, among others. To cite, in April 2018, CE Mark was obtained by Danaher (Beckman Coulter, Inc.) for its DxH 520 hematology analyzer that was particularly developed to assist physician office laboratories.
